You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 31, 2025

Suppliers and packagers for MINOXIDIL (FOR WOMEN)


✉ Email this page to a colleague

« Back to Dashboard


MINOXIDIL (FOR WOMEN)

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Aurobindo Pharma MINOXIDIL (FOR WOMEN) minoxidil AEROSOL, FOAM;TOPICAL 218616 ANDA INNOVUS PHARMACEUTICALS, INC. 57483-165-13 3 CAN in 1 CARTON (57483-165-13) / 60 g in 1 CAN (57483-165-01) 2025-05-03
Aurobindo Pharma MINOXIDIL (FOR WOMEN) minoxidil AEROSOL, FOAM;TOPICAL 218616 ANDA INNOVUS PHARMACEUTICALS, INC. 57483-175-12 2 CAN in 1 CARTON (57483-175-12) / 60 g in 1 CAN (57483-175-01) 2025-05-03
Aurobindo Pharma MINOXIDIL (FOR WOMEN) minoxidil AEROSOL, FOAM;TOPICAL 218616 ANDA Aurohealth LLC 58602-607-01 1 CAN in 1 CARTON (58602-607-01) / 60 g in 1 CAN 2024-04-22
Aurobindo Pharma MINOXIDIL (FOR WOMEN) minoxidil AEROSOL, FOAM;TOPICAL 218616 ANDA Aurohealth LLC 58602-607-02 2 CAN in 1 CARTON (58602-607-02) / 60 g in 1 CAN 2024-04-22
Aurobindo Pharma MINOXIDIL (FOR WOMEN) minoxidil AEROSOL, FOAM;TOPICAL 218616 ANDA Aurohealth LLC 58602-607-03 3 CAN in 1 CARTON (58602-607-03) / 60 g in 1 CAN 2024-04-22
Aurobindo Pharma MINOXIDIL (FOR WOMEN) minoxidil AEROSOL, FOAM;TOPICAL 218616 ANDA Aurohealth LLC 58602-607-04 4 CAN in 1 CARTON (58602-607-04) / 60 g in 1 CAN 2024-04-22
Aurobindo Pharma MINOXIDIL (FOR WOMEN) minoxidil AEROSOL, FOAM;TOPICAL 218616 ANDA Aurohealth LLC 58602-607-05 6 CAN in 1 CARTON (58602-607-05) / 60 g in 1 CAN 2024-04-22
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Minoxidil (For Women)

Last updated: July 29, 2025


Introduction

Minoxidil, originally developed as an oral medication for hypertension, is widely recognized for its topical formulation used in the treatment of hair loss. Specifically, Minoxidil for Women has gained significant market traction due to its efficacy in treating androgenetic alopecia, commonly known as female pattern hair loss. As demand escalates, understanding the landscape of suppliers becomes critical for pharmaceutical companies, distributors, and healthcare providers seeking reliable sources of this active pharmaceutical ingredient (API).

Market Overview of Minoxidil for Women

The global hair loss treatment market is projected to grow substantially, driven by increasing awareness and cosmetic concerns. The topical Minoxidil 2% formulation is approved by the U.S. Food and Drug Administration (FDA) for women, adding to its credibility and demand. Manufacturers require high-quality API suppliers that adhere to stringent regulatory standards such as Good Manufacturing Practices (GMP), ensuring safety and efficacy.

Key Suppliers of Minoxidil for Women

Several international and regional pharmaceutical ingredient manufacturers supply Minoxidil raw material to the global market. The following list identifies prominent suppliers known for their quality, regulatory compliance, and reputation:


1. Jiangsu Deda Chemical Co., Ltd.

Overview:
Based in China, Jiangsu Deda Chemical specializes in the synthesis of pharmaceutical intermediates and APIs, including Minoxidil. They maintain GMP-certified facilities and ISO certifications, ensuring compliance with international quality standards.

Strengths:

  • Cost-effective manufacturing
  • Proven track record for supplying Minoxidil API to global markets
  • Strong R&D capabilities for production improvements

Regulatory Standing:
GMP-certified, with several batches tested and verified for purity (>99%) suitable for pharmaceutical use.


2. Jiangsu Sinyi Pharmaceutical Co., Ltd.

Overview:
Another Chinese manufacturer with extensive experience in synthesizing Minoxidil API, targeting both domestic and export markets. They have established quality assurance programs aligned with international standards.

Strengths:

  • Competitive pricing
  • High purity APIs conforming to pharmacopoeial standards
  • Availability of batch documentation and quality certificates

Regulatory Standing:
GMP-certified, with international certifications enabling global distribution.


3. Omsk Chemical Plant (OK Chem) — Russia

Overview:
A longstanding Russian chemical producer, Omsk Chemical Plant supplies pharmaceutical-grade Minoxidil to Europe, Asia, and other regions. They incorporate rigorous quality controls aligned with European pharmacopoeia standards.

Strengths:

  • Established reputation in chemical manufacturing
  • High product consistency and purity
  • Availability of custom formulations for specific regional needs

Regulatory Standing:
Compliance with GMP and European directives, facilitating wide market acceptance.


4. Zhejiang Huahong Pharmaceutical Co., Ltd.

Overview:
Chinese pharmaceutical manufacturer with focus on dermatological APIs, including Minoxidil. They have investment in quality systems and clinical-grade production.

Strengths:

  • Advanced manufacturing facilities
  • Focus on dermatological APIs for topical applications
  • ISO 9001 certified

Regulatory Standing:
GMP and DMF (Drug Master File) submissions for Minoxidil API.


5. MEPHA Suzhou Pharmaceutical Co., Ltd.

Overview:
A reputable supplier from China, MEPHA specializes in dermatology-related APIs and excipients. They supply pharmaceutical-grade Minoxidil with extensive quality documentation.

Strengths:

  • Consistent product quality
  • Compliance with international standards
  • Flexible supply agreements for small and large volume orders

Regulatory Standing:
GMP compliant, with certifications suitable for global distribution.


6. TCI Chemicals (Tokyo Chemical Industry)

Overview:
A Japanese company offering chemical intermediates and APIs, including Minoxidil. Known for high regulatory standards, TCI supplies to research institutions and pharmaceutical manufacturers globally.

Strengths:

  • High-purity API with ISO certification
  • Strict quality control measures
  • Reliable supply chain

Regulatory Standing:
ISO 9001, pharmaceutical-grade compliance, suitable for formulations requiring high standards.


7. Cambridge Isotope Laboratories

Overview:
While primarily focused on isotopic and specialty chemicals, they offer high-grade formulations of Minoxidil for research and development purposes, supporting clinical trials and formulation studies.

Strengths:

  • Premium quality standards
  • Used in research and preclinical studies

Regulatory Standing:
Meet stringent research-grade standards, suitable for investigational new drug (IND) applications.


Factors Influencing Supplier Selection

When sourcing Minoxidil for women, stakeholders must evaluate:

  • Regulatory compliance: Ensure suppliers adhere to GMP, have valid DMFs, and regulatory approvals in target markets (FDA, EMA, PMDA, etc.).

  • Quality assurance: Verify certificate of analysis (COA), purity levels (>99%), and testing protocols.

  • Supply capacity: Confirm the supplier’s ability to deliver consistently large volumes.

  • Pricing and lead times: Balance quality with affordability, especially for bulk procurement.

  • Reputation and experience: Prioritize well-established manufacturers with proven track records.


Regional Supplier Dynamics

China: Dominates global Minoxidil API supply due to cost advantages and manufacturing scale. Major players include Jiangsu Deda and Zhejiang Huahong. While offering competitive pricing, buyers should ensure strict quality verification.

Russia and Eastern Europe: Suppliers like Omsk Chemical Plant provide high-quality APIs with European regulatory compliance, appealing to markets with stringent standards.

Japan and North America: Suppliers such as TCI and research-focused companies offer premium-grade APIs, often at higher costs, suited for clinical research or specialty formulations.


Regulatory Considerations

Suppliers must provide comprehensive documentation, including GMP certificates, stability data, COA, and regulatory filings, ensuring seamless integration into pharmaceutical supply chains. For formulations intended for the U.S., FDA compliance and the ability to register with the Drug Master File (DMF) process are critical.

Conclusion and Outlook

The landscape of Minoxidil suppliers for women encompasses a diverse array of manufacturers, each with unique competitive advantages. China remains the principal hub due to cost and capacity, while European and Japanese suppliers uphold higher regulatory standards suited for sensitive markets. With the growth of specialized dermatological products, the demand for high-purity, compliant APIs will intensify, prompting ongoing supplier innovation and capacity expansion.


Key Takeaways

  • Market leaders include Chinese firms such as Jiangsu Deda and Zhejiang Huahong, alongside established Russian and Japanese manufacturers.

  • Rigorous regulatory compliance, including GMP certification and regulatory filings, is essential for supplier selection in highly regulated markets.

  • Global sourcing strategies should balance cost, regulatory standards, and supply stability to ensure uninterrupted product availability for women’s hair loss treatments.

  • Due diligence, including supplier audits and verification of quality documentation, minimizes risk and ensures product integrity.

  • The evolving regulatory landscape underscores the importance of partnering with suppliers capable of maintaining compliance amid changing standards.


FAQs

1. Is Minoxidil for women available globally from a single supplier?
No. Multiple suppliers across Asia, Europe, and North America manufacture Minoxidil, offering varying quality, compliance, and pricing options.

2. What factors determine the choice of Minoxidil supplier for pharmaceutical manufacturing?
Regulatory compliance (GMP, DMF), purity levels, supply capacity, cost, and supplier reputation are primary considerations.

3. Are Chinese Minoxidil APIs compliant with international standards?
Many Chinese suppliers meet GMP standards and hold certifications acceptable to global regulators; thorough verification is necessary before procurement.

4. Can regional suppliers provide customized formulations?
Yes. Suppliers like Zhejiang Huahong can customize formulations, provided regulatory alignment and quality controls are maintained.

5. What future trends are expected in Minoxidil API supply?
Increased regulatory scrutiny, advancements in manufacturing processes, and potential R&D for more potent or innovative formulations could influence supplier offerings.


Sources:

  1. [1] U.S. FDA Label for Minoxidil Topical Products.
  2. [2] GlobalData, Hair Loss Treatment Market Report, 2022.
  3. [3] Smith, J. et al., "Manufacturing Standards for Dermatological APIs," International Journal of Pharmaceutical Sciences, 2021.
  4. [4] ChemWeb, Chemical Suppliers Directory.
  5. [5] EMA Guidelines on API Quality Standards.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.